Last reviewed · How we verify

NCT06166264

Effects of Progressive Resistance Training Vasomotor Symptoms in Post Menopausal Women

Status unknown NA Last updated 12 December 2023
What this trial tests

NA trial testing Progressive resistance training in Post Menopausal in 64 participants. Status unknown.

Timeline
5 April 2023
Primary endpoint
1 January 2024
10 January 2024

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment64
Start date5 April 2023
Primary completion1 January 2024
Estimated completion10 January 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 50 to 60, female only, with Post Menopausal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will be a randomized clinical trial and will be conducted in Civil Hospital and Kalsoom Hospital Samundry. This study will be completed in time duration of 10 months after the approval of synopsis. Non probability convenience sampling with Randomization technique will be used and 26 participants will be recruited in study after randomization. The subjects will be divided into two groups and the group A will receive Progressive training and Health education and group B will receive only Health education. The data will be assessed at the baseline and after 8th week of treatment. After data collection data will be analyzed by using SPSS version 21.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Progressive resistance training

Trials testing the same drug.

Other recruiting trials for Post Menopausal

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06166264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing